Publications, Pharmaceutical

Microbial integrity testing for preservative-free drug formulations

Preservative-free formulation can protect patients from the adverse effects of additives and is a growing trend in eye care and nasal drug products.

This paper presents a new tip seal integrity test – TSIT 2.0 – that provides a reasonable and representative challenge for preservative-free solutions with respect to their ability to safeguard microbial integrity. The test uses three germs rather than pseudomonas aeruginosa alone and involves repeated submersion of the discharge orifice during actuation. It is simple, and test duration is relatively short with results generated over a 10-day period. Experimental data are presented to illustrate the application of the new TSIT 2.0 test to an eyedropper. The test is the culmination of a long series of experiments and the results confirm its efficacy for testing the ability of antimicrobial measures to preserve microbial integrity.

Download Publication
3 Jun 2019

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

17 Jun 2021

Nasal Vaccination: Promises and Challenges

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
2 Jun 2021

Aptar Pharma discusses how digital solutions improve patient outcomes

Webinars, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Innovation & Insights, Device Innovations

Read More
18 May 2021

Aptar Pharma discusses trends and benefits of nasal drug delivery

Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Innovation & Insights, Device Innovations

Read More
28 Apr 2021

Using Raman for the characterization of nasal drug suspension products

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
1 16 17 18 19 20 27
Back To Top